<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326647</url>
  </required_header>
  <id_info>
    <org_study_id>jma002</org_study_id>
    <nct_id>NCT04326647</nct_id>
  </id_info>
  <brief_title>Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)</brief_title>
  <acronym>KT-DP</acronym>
  <official_title>Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Castilla-La Mancha</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Castilla-La Mancha</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Berg Test - T0</measure>
    <time_frame>up to week</time_frame>
    <description>Berg Test pre-intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Berg Test - T1</measure>
    <time_frame>up to week</time_frame>
    <description>Berg Test post-intervention two days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Berg Test - T2</measure>
    <time_frame>up to week</time_frame>
    <description>Berg Test post-intervention seven days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tinetti Gait Test - T0</measure>
    <time_frame>up to week</time_frame>
    <description>Tinetti Gait Test pre-intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tinetti Gait Test - T1</measure>
    <time_frame>up to week</time_frame>
    <description>Tinetti Gait Test post-intervention two days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tinetti Gait Test - T2</measure>
    <time_frame>up to week</time_frame>
    <description>Tinetti Gait Test post-intervention seven days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Up &amp; Go Test - T0</measure>
    <time_frame>up to week</time_frame>
    <description>Up &amp; Go Test pre-intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Up &amp; Go Test - T1</measure>
    <time_frame>up to week</time_frame>
    <description>Up &amp; Go Test post-intervention two days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Up &amp; Go Test - T2</measure>
    <time_frame>up to week</time_frame>
    <description>Up &amp; Go Test post-intervention seven days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parkinson's Disease Questionnaire - T0</measure>
    <time_frame>up to month</time_frame>
    <description>Parkinson's Disease Questionnaire pre-intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parkinson's Disease Questionnaire - T1</measure>
    <time_frame>up to month</time_frame>
    <description>Parkinson's Disease Questionnaire post-intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>surface electromyography -T0</measure>
    <time_frame>up to week</time_frame>
    <description>surface electromyography pre-intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>surface electromyography -T1</measure>
    <time_frame>up to week</time_frame>
    <description>surface electromyography post-intervention two days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>surface electromyography -T2</measure>
    <time_frame>up to week</time_frame>
    <description>surface electromyography post-intervention seven days</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Kinesiotaping</condition>
  <arm_group>
    <arm_group_label>Kinesiotaping Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We used kinesiotaping (gastrocnemius and lumbar back) plus exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>We used only exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Kinesiotaping</intervention_name>
    <description>We used kinesiotaping in gastrocnemius and lumbar back</description>
    <arm_group_label>Kinesiotaping Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Exercises about balance and gait</description>
    <arm_group_label>Exercise Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of stage III PD, according to the Hoehn and Yahr scale.

          -  Subjects who are in the age range of 50 to 80 years.

          -  Acceptance of informed consent.

          -  Not present a musculoskeletal disorder or other neurological disease that interferes
             with balance and / or walking.

          -  Not having a diagnosed vestibular disorder.

        Exclusion Criteria:

          -  Diagnosis of parkinsonism o Parkison-Like.

          -  Taking medications that may interfere with the different variables evaluated.

          -  Allergy to any component of the bandage.

          -  Being a pacemaker.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Javier Merino Andrés, MsC</last_name>
    <phone>925268800</phone>
    <phone_ext>5822</phone_ext>
    <email>Javier.Merino@uclm.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Javier Merino Andrés</name>
      <address>
        <city>Toledo</city>
        <zip>45006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

